TRML
Price
$47.89
Change
+$0.02 (+0.04%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
1.23B
VRDN
Price
$20.99
Change
+$0.16 (+0.77%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
1.71B
41 days until earnings call
Interact to see
Advertisement

TRML vs VRDN

Header iconTRML vs VRDN Comparison
Open Charts TRML vs VRDNBanner chart's image
Tourmaline Bio
Price$47.89
Change+$0.02 (+0.04%)
Volume$6.52K
Capitalization1.23B
Viridian Therapeutics
Price$20.99
Change+$0.16 (+0.77%)
Volume$6.78K
Capitalization1.71B
TRML vs VRDN Comparison Chart in %
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRML vs. VRDN commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRML is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (TRML: $47.89 vs. VRDN: $21.00)
Brand notoriety: TRML and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRML: 39% vs. VRDN: 71%
Market capitalization -- TRML: $1.23B vs. VRDN: $1.71B
TRML [@Biotechnology] is valued at $1.23B. VRDN’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRML’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • TRML’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, TRML is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRML’s TA Score shows that 2 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • TRML’s TA Score: 2 bullish, 5 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than TRML.

Price Growth

TRML (@Biotechnology) experienced а +0.13% price change this week, while VRDN (@Biotechnology) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

VRDN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.72B) has a higher market cap than TRML($1.23B). TRML YTD gains are higher at: 136.144 vs. VRDN (9.546). TRML has higher annual earnings (EBITDA): -102.41M vs. VRDN (-340.62M). VRDN has more cash in the bank: 563M vs. TRML (239M). TRML has less debt than VRDN: TRML (145K) vs VRDN (21.3M). VRDN has higher revenues than TRML: VRDN (305K) vs TRML (0).
TRMLVRDNTRML / VRDN
Capitalization1.23B1.72B72%
EBITDA-102.41M-340.62M30%
Gain YTD136.1449.5461,426%
P/E RatioN/AN/A-
Revenue0305K-
Total Cash239M563M42%
Total Debt145K21.3M1%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRMLVRDN
RSI
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMCAX19.83N/A
N/A
Voya MidCap Opportunities A
WEBAX10.64N/A
N/A
TETON Westwood Balanced AAA
PEIQX43.25N/A
N/A
Principal Equity Income R5
TSMGX17.23N/A
N/A
Touchstone Sands Cptl Emerg Mkts Gr A
BSCRX18.51-0.21
-1.12%
Brandes Small Cap Value R6

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+0.04%
SPHDF - TRML
78%
Closely correlated
N/A
DNTH - TRML
41%
Loosely correlated
+0.70%
STOK - TRML
37%
Loosely correlated
+1.86%
ARVN - TRML
36%
Loosely correlated
-3.33%
VRDN - TRML
35%
Loosely correlated
+0.82%
More